Abstract
A 67-year-old woman referred to our clinic complaining of decrease in vision and metamorphopsia for 1 month after initiating latanoprost therapy. Fundus examination and optical coherence tomography (OCT) revealed serous detachment in the macula. The macular thickness measured by OCT was 532 μm. Latanoprost was discontinued. At follow-up, a progressive decrease in macular thickness and increase in visual acuity was observed. Four months later, serous detachment was completely resolved, and macular thickness measured by OCT was 186 μm. Latanoprost may lead a serous retinal detachment in the posterior pole. Clinicians should keep in mind that decreased visual acuity in patients using latanoprost might be related with this complication.
References
Hylton C, Robin AL (2003) Update on prostaglandin analogs. Curr Opin Ophthalmol 13:65–69
Schumer RA, Camras CB, Mandahl AK (2002) Putative side effects of prostaglandin analogs. Surv Ophthalmol 47(Supp 1):219–230
Sauer S, Coracas A, Eckardt CR (2003) Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration. Ophthalmologe 100:62–63
Haimovici R, Koh S, Gagnon DR et al (2004) Risk factors for central serous chorioretinopathy. The central serous chorioretinopathy case-control study group. Ophthalmol 111:244–249
Cellini M, Caramazza R, Bonsanto D et al (2004) Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study. Ophthalmologica 218:312–317
Fechtner RD, Khouri AS, Zimmerman TJ et al (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126:37–41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özkan, B., Karabaş, V.L., Yüksel, N. et al. Serous retinal detachment in the macula related to latanoprost use. Int Ophthalmol 28, 363–365 (2008). https://doi.org/10.1007/s10792-007-9137-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9137-7